Outcomes by prior transarterial chemoembolization (TACE) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Yau, T.; Cheng, A. L.; Meyer, T.; Ryoo, B. Y.; Park, J. W.; Klümpen, H. J.; Lim, H. Y.; Kim, S.; Knox, J.; Patel, M.; El-Khoueiry, A. B.; Kelley, R. K.; Abou-Alfa, G. K. |
| Abstract Title: | Outcomes by prior transarterial chemoembolization (TACE) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy282.087 |
| Language: | English |
| ACCESSION: | WOS:000459277301283 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy282.087 |
| Notes: | Meeting Abstract: 704P -- Appears on pages viii237-viii238 of the abstract book -- Source: Wos |
